1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Drugs
        1.2.3 Devices
    1.3 Market by Application
        1.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Perspective (2017-2028)
    2.2 Benign Prostatic Hyperplasia (BPH) Treatment Growth Trends by Region
        2.2.1 Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Benign Prostatic Hyperplasia (BPH) Treatment Market Dynamics
        2.3.1 Benign Prostatic Hyperplasia (BPH) Treatment Industry Trends
        2.3.2 Benign Prostatic Hyperplasia (BPH) Treatment Market Drivers
        2.3.3 Benign Prostatic Hyperplasia (BPH) Treatment Market Challenges
        2.3.4 Benign Prostatic Hyperplasia (BPH) Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Players by Revenue
        3.1.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Players by Revenue (2017-2022)
        3.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Benign Prostatic Hyperplasia (BPH) Treatment Revenue
    3.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Concentration Ratio
        3.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia (BPH) Treatment Revenue in 2021
    3.5 Benign Prostatic Hyperplasia (BPH) Treatment Key Players Head office and Area Served
    3.6 Key Players Benign Prostatic Hyperplasia (BPH) Treatment Product Solution and Service
    3.7 Date of Enter into Benign Prostatic Hyperplasia (BPH) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Benign Prostatic Hyperplasia (BPH) Treatment Breakdown Data by Type
    4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Type (2023-2028)
5 Benign Prostatic Hyperplasia (BPH) Treatment Breakdown Data by Application
    5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2017-2028)
    6.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
        6.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022)
        6.2.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028)
        6.2.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2017-2028)
    6.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
        6.3.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022)
        6.3.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028)
        6.3.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2017-2028)
    6.4 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
        6.4.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022)
        6.4.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2017-2028)
    7.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
        7.2.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2017-2028)
    7.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
        7.3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2017-2028)
    7.4 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
        7.4.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
        8.2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
        8.3.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region
        8.4.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2017-2028)
    9.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
        9.2.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2017-2028)
    9.3 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
        9.3.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2017-2028)
    9.4 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
        9.4.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
        10.2.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
        10.3.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
        10.4.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Benign Prostatic Hyperplasia (BPH) Treatment Introduction
        11.1.4 Pfizer Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Benign Prostatic Hyperplasia (BPH) Treatment Introduction
        11.2.4 Sanofi Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
        11.2.5 Sanofi Recent Developments
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Treatment Introduction
        11.3.4 GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Developments
    11.4 Boston Scientific
        11.4.1 Boston Scientific Company Details
        11.4.2 Boston Scientific Business Overview
        11.4.3 Boston Scientific Benign Prostatic Hyperplasia (BPH) Treatment Introduction
        11.4.4 Boston Scientific Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
        11.4.5 Boston Scientific Recent Developments
    11.5 Teleflex
        11.5.1 Teleflex Company Details
        11.5.2 Teleflex Business Overview
        11.5.3 Teleflex Benign Prostatic Hyperplasia (BPH) Treatment Introduction
        11.5.4 Teleflex Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
        11.5.5 Teleflex Recent Developments
    11.6 Cardinal Health
        11.6.1 Cardinal Health Company Details
        11.6.2 Cardinal Health Business Overview
        11.6.3 Cardinal Health Benign Prostatic Hyperplasia (BPH) Treatment Introduction
        11.6.4 Cardinal Health Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
        11.6.5 Cardinal Health Recent Developments
    11.7 Allergan
        11.7.1 Allergan Company Details
        11.7.2 Allergan Business Overview
        11.7.3 Allergan Benign Prostatic Hyperplasia (BPH) Treatment Introduction
        11.7.4 Allergan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
        11.7.5 Allergan Recent Developments
    11.8 Teva Pharmaceutical
        11.8.1 Teva Pharmaceutical Company Details
        11.8.2 Teva Pharmaceutical Business Overview
        11.8.3 Teva Pharmaceutical Benign Prostatic Hyperplasia (BPH) Treatment Introduction
        11.8.4 Teva Pharmaceutical Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
        11.8.5 Teva Pharmaceutical Recent Developments
    11.9 Mylan
        11.9.1 Mylan Company Details
        11.9.2 Mylan Business Overview
        11.9.3 Mylan Benign Prostatic Hyperplasia (BPH) Treatment Introduction
        11.9.4 Mylan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
        11.9.5 Mylan Recent Developments
    11.10 Eli Lilly
        11.10.1 Eli Lilly Company Details
        11.10.2 Eli Lilly Business Overview
        11.10.3 Eli Lilly Benign Prostatic Hyperplasia (BPH) Treatment Introduction
        11.10.4 Eli Lilly Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
        11.10.5 Eli Lilly Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Drugs
    Table 3. Key Players of Devices
    Table 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Region (2017-2022)
    Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Region (2023-2028)
    Table 10. Benign Prostatic Hyperplasia (BPH) Treatment Market Trends
    Table 11. Benign Prostatic Hyperplasia (BPH) Treatment Market Drivers
    Table 12. Benign Prostatic Hyperplasia (BPH) Treatment Market Challenges
    Table 13. Benign Prostatic Hyperplasia (BPH) Treatment Market Restraints
    Table 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Players (2017-2022)
    Table 16. Global Top Benign Prostatic Hyperplasia (BPH) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment as of 2021)
    Table 17. Ranking of Global Top Benign Prostatic Hyperplasia (BPH) Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Benign Prostatic Hyperplasia (BPH) Treatment Product Solution and Service
    Table 21. Date of Enter into Benign Prostatic Hyperplasia (BPH) Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Type (2017-2022)
    Table 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Type (2023-2028)
    Table 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Application (2017-2022)
    Table 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Application (2023-2028)
    Table 31. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Pfizer Company Details
    Table 62. Pfizer Business Overview
    Table 63. Pfizer Benign Prostatic Hyperplasia (BPH) Treatment Product
    Table 64. Pfizer Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
    Table 65. Pfizer Recent Developments
    Table 66. Sanofi Company Details
    Table 67. Sanofi Business Overview
    Table 68. Sanofi Benign Prostatic Hyperplasia (BPH) Treatment Product
    Table 69. Sanofi Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
    Table 70. Sanofi Recent Developments
    Table 71. GlaxoSmithKline Company Details
    Table 72. GlaxoSmithKline Business Overview
    Table 73. GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Treatment Product
    Table 74. GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
    Table 75. GlaxoSmithKline Recent Developments
    Table 76. Boston Scientific Company Details
    Table 77. Boston Scientific Business Overview
    Table 78. Boston Scientific Benign Prostatic Hyperplasia (BPH) Treatment Product
    Table 79. Boston Scientific Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
    Table 80. Boston Scientific Recent Developments
    Table 81. Teleflex Company Details
    Table 82. Teleflex Business Overview
    Table 83. Teleflex Benign Prostatic Hyperplasia (BPH) Treatment Product
    Table 84. Teleflex Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
    Table 85. Teleflex Recent Developments
    Table 86. Cardinal Health Company Details
    Table 87. Cardinal Health Business Overview
    Table 88. Cardinal Health Benign Prostatic Hyperplasia (BPH) Treatment Product
    Table 89. Cardinal Health Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
    Table 90. Cardinal Health Recent Developments
    Table 91. Allergan Company Details
    Table 92. Allergan Business Overview
    Table 93. Allergan Benign Prostatic Hyperplasia (BPH) Treatment Product
    Table 94. Allergan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
    Table 95. Allergan Recent Developments
    Table 96. Teva Pharmaceutical Company Details
    Table 97. Teva Pharmaceutical Business Overview
    Table 98. Teva Pharmaceutical Benign Prostatic Hyperplasia (BPH) Treatment Product
    Table 99. Teva Pharmaceutical Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
    Table 100. Teva Pharmaceutical Recent Developments
    Table 101. Mylan Company Details
    Table 102. Mylan Business Overview
    Table 103. Mylan Benign Prostatic Hyperplasia (BPH) Treatment Product
    Table 104. Mylan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
    Table 105. Mylan Recent Developments
    Table 106. Eli Lilly Company Details
    Table 107. Eli Lilly Business Overview
    Table 108. Eli Lilly Benign Prostatic Hyperplasia (BPH) Treatment Product
    Table 109. Eli Lilly Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
    Table 110. Eli Lilly Recent Developments
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Drugs Features
    Figure 3. Devices Features
    Figure 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application: 2021 VS 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Benign Prostatic Hyperplasia (BPH) Treatment Report Years Considered
    Figure 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Region: 2021 VS 2028
    Figure 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Players in 2021
    Figure 13. Global Top Benign Prostatic Hyperplasia (BPH) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Revenue in 2021
    Figure 15. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Type (2017-2028)
    Figure 17. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Application (2017-2028)
    Figure 18. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Country (2017-2028)
    Figure 19. United States Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Country (2017-2028)
    Figure 25. Germany Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Region (2017-2028)
    Figure 35. China Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Country (2017-2028)
    Figure 45. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Country (2017-2028)
    Figure 51. Turkey Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Pfizer Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
    Figure 55. Sanofi Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
    Figure 56. GlaxoSmithKline Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
    Figure 57. Boston Scientific Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
    Figure 58. Teleflex Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
    Figure 59. Cardinal Health Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
    Figure 60. Allergan Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
    Figure 61. Teva Pharmaceutical Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
    Figure 62. Mylan Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
    Figure 63. Eli Lilly Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed